Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kirin-Amgen

1984 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer and supplier of medical drugs. The company's medical drugs include erythropoietin, granulocyte colony-stimulating factor, darbepoetin alfa and related drugs, enabling patients and medical institutions to get a consistent supply of medicines throughout the year.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • One Amgen Center Drive
  • Thousand Oaks, CA 91320
  • United States

Kirin-Amgen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kirin-Amgen‘s full profile, request access.

Request full access to PitchBook

Kirin-Amgen Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Kirin-Amgen‘s full profile, request access.

Request full access to PitchBook

Kirin-Amgen Executive Team (1)

Name Title Board
Seat
Contact
Info
George Rathmann Chief Executive Officer